AOD 9604 Peptide Product Overview
AOD 9604 Peptide (also known as HGH Fragment 176-191) is a synthetic 16-amino acid peptide derived from the C-terminal region of human Growth Hormone (hGH), specifically corresponding to amino acid residues 176–191 of the 191-amino acid hGH molecule . Originally developed by Metabolic Pharmaceuticals in the late 1990s, this modified peptide fragment was engineered to isolate the lipolytic (fat-breaking) properties of growth hormone while minimizing effects on insulin sensitivity and glucose metabolism .
The peptide incorporates a tyrosine residue at the N-terminus, a modification theorized to support stability and activity . Unlike full-length growth hormone, AOD 9604 does not activate GH receptors and was designed to avoid the IGF-1 and insulin-resistance effects associated with full HGH protocols . AOD 9604 is on the World Anti-Doping Agency (WADA) Prohibited List and is not approved by the FDA for human therapeutic use.
AOD 9604 Peptide Mechanism of Action
AOD 9604 functions as a lipolytic agent through pathways distinct from full-length growth hormone. Research indicates the peptide:
-
Stimulates Lipolysis: Promotes the breakdown of stored fat (triglycerides) into free fatty acids and glycerol
-
Inhibits Lipogenesis: Reduces the formation of new fat deposits
-
β3 Adrenergic Receptor Signaling: Its mechanism depends, at least in part, on intact β3 adrenergic receptor signaling pathways
-
GH-Sparing Profile: Lacks the growth-promoting and glucose-modulating effects of full HGH
Key Research Applications:
-
Adipose tissue metabolism and fat oxidation studies
-
Lipid profile and cholesterol regulation research
-
Obesity and metabolic syndrome pathway investigations
-
Cartilage repair and tissue regeneration studies
AOD 9604 Peptide Product Specifications
| Parameter | Specification |
|---|---|
| Product Name | AOD 9604 (HGH Fragment 176-191) |
| Synonyms | AOD-9604, HGH Fragment 176-191, Anti-Obesity Drug |
| Molecular Formula | C₇₈H₁₂₃N₂₃O₂₃S₂ (Free Base) |
| Molecular Weight | ~1815.1 g/mol (Free Base) |
| CAS Number | 221231-10-3 |
| Sequence | H-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH |
| Purity | ≥99% (by HPLC area) |
| Form | White to off-white lyophilized powder |
| Peptide Content | ≥70% |
| Water Content | ≤5.0% |
| Endotoxin Level | <0.25 EU/mg |
| Storage | -20°C (long-term); 2-8°C (short-term), protected from light |
| Solubility | Soluble in sterile water (≥1 mg/mL) |
AOD 9604 Peptide Quality Assurance
Every batch of AOD 9604 undergoes rigorous analytical testing to ensure maximum purity and research integrity:
| Test | Method | Specification |
|---|---|---|
| Identity | ESI-MS | Matches theoretical mass of 1815.1 Da |
| Purity | RP-HPLC | ≥99% area |
| Sequence Confirmation | MS/MS | 100% sequence coverage |
| Water Content | Karl Fischer | ≤5.0% |
| Endotoxin | LAL Test | <0.25 EU/mg |
| Microbial Limits | USP <61> | <100 CFU/g; no pathogens |
Certificate of Analysis (COA) available upon request.
Storage & Reconstitution Guidelines
Storage Conditions:
-
Lyophilized (Long-term): -20°C, protected from light and moisture
-
Lyophilized (Short-term): 2°C – 8°C (refrigerated)
-
Reconstituted: 4°C for up to 7 days; avoid repeated freeze-thaw cycles
Note: Peptides are sensitive to formulation, process, and environmental conditions that may lead to aggregation and degradation .
Important Notice
⚠️ FOR RESEARCH USE ONLY
This product is not intended for human consumption, diagnostic use, therapeutic application, or clinical administration. AOD 9604 is a research chemical intended exclusively for in-vitro and laboratory research purposes .
-
Not approved by the FDA for human use
-
Listed on the WADA Prohibited List (Section S2.2)
-
Not a dietary supplement, food additive, or pharmaceutical
-
Intended solely for qualified researchers and scientific institutions
By purchasing this product, you confirm that you are a licensed researcher or laboratory professional and agree to use this compound in compliance with all applicable local, national, and international regulations.
Why Choose PeptidesUnit.com?
| Feature | Benefit |
|---|---|
| ✅ Premium Purity | ≥99% HPLC-verified purity guaranteed |
| ✅ Research-Grade Quality | Manufactured under GMP-aligned conditions |
| ✅ Third-Party Tested | Independent COA for every batch |
| ✅ Secure Packaging | Lyophilized in amber glass vials with tamper-evident seals |
| ✅ Fast Global Shipping | Discreet packaging with real-time tracking |
| ✅ Competitive Pricing | Direct-from-manufacturer pricing |
| ✅ Customer Support | Dedicated research support team |
Order Now
AOD 9604 (HGH Fragment 176-191) 5mg – ≥99% Purity
Available for immediate shipment
🛒 BUY NOW at PeptidesUnit.com
AOD 9604 Peptide for Weight Loss: A Complete Guide | Reload Centre Pharmacy
Introduction: Understanding AOD 9604 Peptide
For those seeking a scientifically-supported approach to targeting stubborn fat, AOD 9604 has emerged as one of the most promising peptides in metabolic science. Originally developed by researchers at Monash University, this synthetic peptide offers targeted fat-burning properties without significant side effects. At Reload Centre Pharmacy, we provide pharmaceutical-grade AOD 9604 with the purity and documentation that serious users require. This comprehensive guide explores how AOD 9604 works, its benefits, proper protocols, and why sourcing from a reputable pharmacy matters. AOD 9604 Peptide
What is AOD 9604 Peptide?
AOD 9604 (Advanced Obesity Drug 9604) is a modified fragment of human growth hormone (HGH), specifically consisting of the 177-191 amino acid sequence. Unlike full-length HGH, this fragment has been modified to retain the fat-burning properties while eliminating the growth-promoting effects that can cause side effects. This makes AOD 9604 a targeted approach to weight management with a more favorable safety profile.
Mechanism of Action: How AOD 9604 Peptide Works
AOD 9604 operates through several distinct pathways:
AOD 9604 Peptide Targeted Fat Metabolism
The peptide specifically stimulates lipolysis (fat breakdown) while inhibiting lipogenesis (fat storage). Unlike systemic stimulants, it appears to preferentially target adipocytes (fat cells) in problematic areas, particularly abdominal fat.
Hormone-Sensitive Lipase Activation
AOD 9604 increases the activity of hormone-sensitive lipase, the enzyme responsible for breaking down stored triglycerides into free fatty acids that can be used for energy.
AOD 9604 Peptide Improved Insulin Sensitivity
Research indicates AOD 9604 may enhance insulin sensitivity, helping regulate blood glucose levels and reducing the likelihood of excess glucose being stored as fat.
AOD 9604 Peptide Metabolic Rate Support
By optimizing fat metabolism pathways, AOD 9604 may help maintain a healthier metabolic rate, even during calorie restriction.
Clinical Research and Evidence Base
Original Research Findings
The development of AOD 9604 was supported by research showing:
-
Significant reduction in body fat in animal studies
-
No impact on blood glucose levels (unlike full HGH)
-
No observed growth effects on bones or organs
-
Positive effects on cholesterol metabolism
Human Trial Results
While further human studies are warranted, available research indicates:
-
Weight loss in obese patients when combined with diet
-
Reduction in waist circumference measurements
-
Improved body composition parameters
-
Good tolerability with minimal side effects
Benefits of AOD 9604 Peptide Therapy
AOD 9604 Peptide Targeted Fat Reduction
-
Particularly effective for stubborn abdominal fat
-
May reduce visceral fat surrounding organs
-
Helps improve body shape and proportions
AOD 9604 Peptide Metabolic Advantages
-
Supports fat loss during calorie restriction
-
May help prevent metabolic adaptation during dieting
-
Could improve lipid profile parameters
Favorable Safety Profile
-
No significant effect on blood glucose levels
-
Minimal to no water retention
-
No reported serious adverse effects in studies
-
Non-habit forming with no withdrawal effects
Proper AOD 9604 Protocol and Administration
Recommended Dosage
-
Research suggests 300-500 mcg per day
-
Typically administered once daily
-
Often used in cycles of 8-12 weeks
-
Individual adjustments based on response
Administration Method
-
Subcutaneous injection (similar to insulin administration)
-
Common injection sites: abdominal area, thighs
-
May be taken in morning or pre-exercise
-
Requires proper sterile technique
Cycle Considerations
-
Often cycled with periods of rest
-
May be stacked with complementary peptides
-
Should be part of comprehensive wellness approach
-
Professional guidance recommended for optimization
Why Source AOD 9604 from a Professional Pharmacy
Pharmaceutical-Grade Quality
At Reload Centre Pharmacy, our AOD 9604 meets exacting standards:
-
99% purity verified by HPLC testing
-
Sterile preparation in certified facilities
-
Accurate concentration and proper formulation
-
Complete Certificate of Analysis available
Stability and Potency
-
Proper lyophilized (freeze-dried) presentation
-
Correct storage and shipping protocols
-
Clear expiration dating
-
Reconstitution guidance provided
Professional Support
-
Access to educational resources
-
Guidance on proper protocol development
-
Support for integrating with lifestyle factors
-
Emphasis on safe administration practices
Integrating AOD 9604 into Your Wellness Strategy
Synergistic Lifestyle Factors
For optimal results, AOD 9604 should be combined with:
-
Appropriate nutrition plan with moderate calorie deficit
-
Regular physical activity, including resistance training
-
Adequate sleep and stress management
-
Consistent hydration and micronutrient support
Realistic Expectations
-
Individual response varies based on multiple factors
-
Not a substitute for foundational lifestyle habits
-
Works best as part of comprehensive approach
-
Results typically become noticeable after several weeks
Monitoring Progress
-
Regular body composition measurements
-
Waist circumference tracking
-
Energy levels and workout performance
-
Overall well-being and metabolic markers
Safety Considerations and Side Effects
Generally Well-Tolerated
-
Most users report minimal side effects
-
Rare injection site reactions
-
No significant hormone disruption reported
-
Good safety profile in research studies
Important Precautions
-
Not recommended during pregnancy or breastfeeding
-
Should be used with medical guidance if diabetic
-
Requires sterile administration to prevent infection
-
Professional supervision recommended
Contraindications
-
Active cancer or tumor history
-
Severe kidney or liver impairment
-
Allergy to any components
-
Under 25 years old (unless medically indicated)
Frequently Asked Questions
Q: How quickly can I expect results with AOD 9604 Peptide?
A: Most users notice changes in body composition within 4-8 weeks when combined with proper diet and exercise.
Q: Can women use AOD 9604 Peptide?
A: Yes, AOD 9604 is suitable for both men and women seeking targeted fat reduction.
Q: Is AOD 9604 a growth hormone?
A: No, it’s a modified fragment that retains fat-burning properties without growth effects.
Q: Do I need a prescription for AOD 9604 Peptide?
A: Requirements vary by location. We recommend consulting with a healthcare provider.
Q: How should AOD 9604 be stored?
A: Unreconstituted peptides should be refrigerated. Once reconstituted, follow specific storage guidelines.
Conclusion: A Targeted Approach to Body Composition
AOD 9604 represents a significant advancement in peptide science, offering targeted fat metabolism support with a favorable safety profile. When sourced from a reputable pharmacy like Reload Centre and integrated into a comprehensive wellness strategy, it can be a valuable tool for overcoming stubborn fat loss plateaus and improving body composition.
Explore Pharmaceutical-Grade AOD 9604 Peptide
Discover how pharmaceutical-grade AOD 9604 from Reload Centre Pharmacy can support your body composition goals. Learn about our quality standards, professional resources, and commitment to excellence in peptide therapy.







Reviews
There are no reviews yet